You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PET N-13 ammonia imaging

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ammonia N-13 Myocardial Blood Flow Absolute Quantification by

Recruiting
  • Myocardial Ischemia
  • +7 more
  • Myocardial Perfusion Imaging Study
  • AMMONIA N-13 37.5 mCi in 1 mL INTRAVENOUS INJECTION [Ammonia N 13]
  • Miami, Florida
  • +3 more
Jan 4, 2023

Sickle Cell Disease Trial in Memphis ([13N]NH3, Lexiscan, Positron emission tomography)

Not yet recruiting
  • Sickle Cell Disease
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 11, 2023

Coronary Artery Disease Trial in Saint Louis (Ga-68 Galmydar, 13N-ammonia)

Recruiting
  • Coronary Artery Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 20, 2022

Amyloidosis, Primary, Cardiomyopathy Trial in Boston (F-18 florbetapir/C-11 acetate PET, MRI, N-13 ammonia PET)

Recruiting
  • Amyloidosis, Primary
  • Cardiomyopathy
  • F-18 florbetapir/C-11 acetate PET
  • +2 more
  • Boston, Massachusetts
    Brigham and Womens' Hospital
Oct 23, 2022

Quantitative 13N-Ammonia Cardiac Rest/Stress Digital PET/CT

Completed
  • Coronary Artery Disease
  • Cardiac Perfusion Rest/Stress Digital PET/CT
  • +2 more
  • Stanford, California
    Stanford University
Oct 24, 2021

N-13 Ammonia Safety Trial in Montréal (N-13 ammonia intravenous injection)

Recruiting
  • N-13 Ammonia Safety
  • N-13 ammonia intravenous injection
  • Montréal, Quebec, Canada
    Centre Hospitalier de l'université de Montréal
Aug 5, 2022

Myocardial Infarction, Coronary Microvascular Dysfunction, Vasospasm, Coronary Trial in Gwangju (Intravascular imaging (OCT),

Recruiting
  • Myocardial Infarction
  • +2 more
  • Intravascular imaging (OCT), Invasive physiologic assessment (FFR, CFR, IMR), or Non-invasive physiologic assessment (N-13 ammonia PET)
  • Gwangju, Korea, Republic of
    Chonnam National University Hospital
Mar 13, 2022

Coronary Disease Trial in Beijing (18F-FMPP)

Unknown status
  • Coronary Disease
  • Beijing, Dongcheng, China
    Peking union medical college hospital
Oct 21, 2020

Tumors Trial in Beijing ([68Ga]N188)

Recruiting
  • Neoplasms
  • Beijing, Beijing, China
    Peking University First Hospital
Jan 27, 2023

Breast Cancer Female, Breast Cancer Recurrent Trial in Drammen (18F-FDG PET/CT)

Recruiting
  • Breast Cancer Female
  • Breast Cancer Recurrent
  • 18F-FDG PET/CT
  • Drammen, Norway
    Drammen Hospital - Vestre Viken HF
Feb 17, 2023

Depression Trial run by the NIMH (11C-MCI, 11CPS13)

Recruiting
  • Depression
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Multiple Sclerosis Trial run by the NIMH (11C-MCI, 11C-PS13)

Recruiting
  • Multiple Sclerosis
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023

68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors

Recruiting
  • Neuroendocrine Tumors (NET)
  • 68Ga-HA-DOTATATE PET/CT imaging
  • Calgary, Alberta, Canada
    Foothills Medical Center 1403 29 St NW
Jan 4, 2023

Breast Cancer, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, Injection of hyperpolarized

Enrolling by invitation
  • Breast Cancer
  • +3 more
  • Copenhagen, Denmark
    Rigshospitalet
Jan 18, 2023

Myocardial Perfusion Imaging by Combined 15O-H2O PET and MR

Completed
  • Ischemic Heart Disease
    • Aarhus, Aarhus N, Denmark
      Aarhus University Hospital
    Dec 21, 2022

    Biomarkers of Risk of Parkinson Disease

    Active, not recruiting
    • Parkinson Disease
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 13, 2023

    Total-body 13N-NH3 PET/CT to Study Blood Perfusion in Whole Body

    Recruiting
    • Cardiac Output
    • total-body PET/CT(uEXPLORER , United Imaging Healthcare, China)
    • Shanghai, Shanghai, China
      Shanghai jiaotong University School of Medicine, Renji Hospital
    Sep 24, 2021

    Benign Kidney Tumor, Kidney Tumor, Renal Cell Cancer Trial in San Francisco (Hyperpolarized Carbon C 13 Pyruvate, Magnetic

    Recruiting
    • Benign Kidney Neoplasm
    • +2 more
    • Hyperpolarized Carbon C 13 Pyruvate
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Jan 6, 2023

    Chronic Right-Sided Heart Failure, Pulmonary Arterial Hypertension, Pulmonary Hypertension, Primary, 2 Trial in Ottawa (drug,

    Recruiting
    • Chronic Right-Sided Heart Failure
    • +5 more
    • Ottawa, Ontario, Canada
      University of Ottawa Heart Institute
    Nov 19, 2021

    Endometrial Cancer, Ovarian Cancer Trial in Sherbrooke (Loperamide Pill, hyoscine-n-butylbromide)

    Recruiting
    • Endometrial Cancer
    • Ovarian Cancer
    • Sherbrooke, Quebec, Canada
      Centre de recherche du CHUS
    Oct 31, 2022

    Uterine Cervical Tumors Trial in Toronto (Hyperpolarized 13C-Pyruvate, 18F-FDG)

    Terminated
    • Uterine Cervical Neoplasms
    • Toronto, Ontario, Canada
      Sunnybrook Health Sciences Centre
    Sep 20, 2022

    Neuroblastoma Trial in Montréal, Sherbrooke (Radiopharmaceutical 68Ga-DOTATATE)

    Recruiting
    • Neuroblastoma
    • Radiopharmaceutical 68Ga-DOTATATE
    • Montréal, Quebec, Canada
    • +2 more
    Jan 3, 2023

    Prostate Cancer Trial in Toronto (Hyperpolarized Pyruvate (13C))

    Recruiting
    • Prostate Cancer
    • Hyperpolarized Pyruvate (13C)
    • Toronto, Ontario, Canada
      Sunnybrook Health Sciences Centre
    May 4, 2022

    ER+ Breast Cancer Trial in Sherbrooke (4FMFES-PET)

    Recruiting
    • ER+ Breast Cancer
    • 4FMFES-PET
    • Sherbrooke, Quebec, Canada
      Université deSherbrooke
    Jul 18, 2022

    Hepatocellular Carcinoma Trial in Toronto (PET MRI)

    Active, not recruiting
    • Hepatocellular Carcinoma
    • PET MRI
    • Toronto, Ontario, Canada
      Toronto General Hospital
    Oct 31, 2022